SINUS DILATION DEVICES MARKET ANALYSIS

Sinus Dilation Devices Market, by Product Type (Balloon Sinuplasty Systems Rhinoscopes, Sinuscopes, Sinus Stents, Functional Endoscopic Sinus Surgery (FESS) Instruments Set, and Others), by End User (Hospitals & Clinics and Ambulatory Surgical Centers (ASCs)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

Published In : Jan 2019
Code : CMI2451
Pages :160
Formats :
Excel and PDF
Industry : Medical Devices

Regional Analysis

North America holds dominant position in the global sinus dilation devices market, owing to high availability of sinus dilation devices in medical settings. Medications such as antibiotics and topical steroids help to open up blocked sinus passages and relieve symptoms. However, these medicines serve as short-term relive and do not fix the condition permanently, therefore, many people in the U.S. are adopting surgical methods for the treatment of this condition. According to the research published in the National Center for Biotechnology Information (NCBI), over 600,000 ambulatory sinonasal cases are performed each year in the U.S.

One of the minimally invasive and most favorable technique is Balloon Sinus Dilation (BSD). The balloon sinus dilation opens inflamed sinuses restoring normal sinus drainage and function often without tissue or bone removal. According to Entellus Inc.’s annual report, around 552,000 patients underwent FESS procedures in the U.S. in 2015. Out of which, over 55% were well suited for balloon sinus dilation, and the supplementary 30% were apt for hybrid balloon sinus dilation (BSD with FESS).